Biomedical innovation 'made in Spain': Challenges and opportunities in the long race to ma... 13/05/2025 Healthcare Access to innovation Financing Experts from the sector highlighted at the 18th Annual Conference of the Biomedical Research Technology Platforms the... AseBio
Biomedical innovation 'made in Spain': Challenges and opportunities in the long race to ma... 13/05/2025 Experts from the sector highlighted at the 18th Annual Conference of the Biomedical Research Technology Platforms the... AseBio
ORYZON awarded 13.26 million € through the first Important Project of Common European Inte... 08/05/2025 Healthcare Rare diseases Innovative drugs Oryzon to validate epigenetic agents by applying a personalized medicine approach for rare and orphan diseases. Partners - Oryzon Genomics
Theriva™ Biologics Announces Primary Endpoints for Efficacy and Safety Achieved in VIRAGE ... 08/05/2025 Healthcare Access to innovation Innovative drugs Patients treated with VCN-01 (zabilugene almadenorepvec) plus gemcitabine/nab-paclitaxel standard-of-care (SoC)... Partners
Nuage Therapeutics, Ona Therapeutics, and SpliceBio are leading the wave of biotech innova... 05/05/2025 Healthcare Rare diseases Personalized medicine Advanced therapies Las biotecnológicas Nuage Therapeutics, Ona Therapeutics y SpliceBio, con sede en el Parque Científico de Barcelona, han... Partners - Parc Científic de Barcelona
I4ID 2025 Lyon Francia Del 13/11/2025 to 14/11/2025 Healthcare Innovative drugs 9th Immunotherapies and Innovations for Infectious Diseases Congress
BioPC 2025 - 10th Bioproduction Congress Lyon France Del 22/09/2025 to 23/09/2025 Healthcare Advanced therapies
#NewAseBioMember | "We believe that AseBio can serve as an important tool for expanding co... 05/05/2025 Healthcare Corporate Meet our new member MedBioinformatics. We sponke with Ferran Sanz, Founding Partner, Member of the Board of Directors... AseBio - MEDBIOINFORMATICS SOLUTIONS
